Headline News about Altimmune, Inc. - Common Stock![]() ![]() ![]()
Altimmune Touts Encouraging Data From Fatty Liver Disease Study
December 20, 2022
Via Benzinga
![]()
Recent Selloff Is A 'Buying Opportunity' For This NASH Stock, Says Analyst
September 16, 2022
Via Benzinga
![]() ![]() ![]() ![]()
Altimmune Shares Fall Despite Fatty Liver Disease Study Meets Primary Goal
September 14, 2022
Via Benzinga
![]()
Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2022
December 01, 2022
Via Benzinga
![]()
My 3 Top Biotech Stock Picks for 2023
November 22, 2022
Via The Motley Fool
![]() ![]() ![]() ![]() ![]() ![]()
Important Biotech Catalysts For September 14, 2022 - End Of The Day Summary
September 14, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|